JP2022183342A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022183342A5 JP2022183342A5 JP2022168742A JP2022168742A JP2022183342A5 JP 2022183342 A5 JP2022183342 A5 JP 2022183342A5 JP 2022168742 A JP2022168742 A JP 2022168742A JP 2022168742 A JP2022168742 A JP 2022168742A JP 2022183342 A5 JP2022183342 A5 JP 2022183342A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- pharmaceutical composition
- medicament
- group
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 claims 21
- 239000003814 drug Substances 0.000 claims 14
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 241000991587 Enterovirus C Species 0.000 claims 9
- 101000586618 Homo sapiens Poliovirus receptor Proteins 0.000 claims 9
- 102100029740 Poliovirus receptor Human genes 0.000 claims 9
- 241000710124 Human rhinovirus A2 Species 0.000 claims 8
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 claims 8
- 208000005017 glioblastoma Diseases 0.000 claims 6
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims 5
- 102000037984 Inhibitory immune checkpoint proteins Human genes 0.000 claims 5
- 108091008026 Inhibitory immune checkpoint proteins Proteins 0.000 claims 5
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims 5
- 206010006187 Breast cancer Diseases 0.000 claims 4
- 208000026310 Breast neoplasm Diseases 0.000 claims 4
- 241000274177 Juniperus sabina Species 0.000 claims 4
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims 4
- 108700026244 Open Reading Frames Proteins 0.000 claims 4
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 4
- 208000014829 head and neck neoplasm Diseases 0.000 claims 4
- 201000001441 melanoma Diseases 0.000 claims 4
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562242123P | 2015-10-15 | 2015-10-15 | |
| US62/242,123 | 2015-10-15 | ||
| US201662361725P | 2016-07-13 | 2016-07-13 | |
| US62/361,725 | 2016-07-13 | ||
| JP2020129898A JP2020183447A (ja) | 2015-10-15 | 2020-07-31 | 併用療法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020129898A Division JP2020183447A (ja) | 2015-10-15 | 2020-07-31 | 併用療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022183342A JP2022183342A (ja) | 2022-12-08 |
| JP2022183342A5 true JP2022183342A5 (https=) | 2022-12-21 |
Family
ID=58518110
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018519304A Active JP6850290B2 (ja) | 2015-10-15 | 2016-10-14 | 併用療法 |
| JP2020129898A Withdrawn JP2020183447A (ja) | 2015-10-15 | 2020-07-31 | 併用療法 |
| JP2022168742A Pending JP2022183342A (ja) | 2015-10-15 | 2022-10-21 | 併用療法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018519304A Active JP6850290B2 (ja) | 2015-10-15 | 2016-10-14 | 併用療法 |
| JP2020129898A Withdrawn JP2020183447A (ja) | 2015-10-15 | 2020-07-31 | 併用療法 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US10744170B2 (https=) |
| EP (1) | EP3362091A4 (https=) |
| JP (3) | JP6850290B2 (https=) |
| CN (1) | CN108697788A (https=) |
| WO (1) | WO2017066557A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108112254B (zh) | 2015-03-13 | 2022-01-28 | 西托姆克斯治疗公司 | 抗-pdl1抗体、可活化的抗-pdl1抗体、及其使用方法 |
| MX383464B (es) | 2015-07-13 | 2025-03-14 | Cytomx Therapeutics Inc | Anticuerpos anti-pd-1, anticuerpos anti-pd-1 activables, y métodos de uso de los mismos. |
| WO2018067446A1 (en) | 2016-10-06 | 2018-04-12 | Duke University | Detection of cd-155, the poliovirus receptor |
| EP3525822A4 (en) | 2016-10-17 | 2020-05-06 | Duke University | PRODUCTION OF IMMUNOTOXIN D2C7- (SCDSFV) -PE38KDEL |
| CN110914302A (zh) | 2017-06-01 | 2020-03-24 | 赛托姆克斯治疗学股份有限公司 | 可活化抗pdl1抗体及其使用方法 |
| JP7550449B2 (ja) * | 2018-04-02 | 2024-09-13 | デューク ユニバーシティ | ネオアジュバントがん治療 |
| EP4051321A4 (en) | 2019-10-30 | 2023-11-22 | Duke University | IMMUNOTHERAPY WITH COMBINATION THERAPY INCLUDING AN IMMUNOTOXIN |
| US20220387529A1 (en) * | 2019-11-04 | 2022-12-08 | Duke University | Treatment for primary and metastatic cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8066983B2 (en) | 2008-03-14 | 2011-11-29 | The Research Foundation Of State University Of New York | Attenuated poliovirus |
| WO2013112942A1 (en) * | 2012-01-25 | 2013-08-01 | Dna Trix, Inc. | Biomarkers and combination therapies using oncolytic virus and immunomodulation |
| US20150250837A1 (en) * | 2012-09-20 | 2015-09-10 | Morningside Technology Ventures Ltd. | Oncolytic virus encoding pd-1 binding agents and uses of the same |
| CN104936608A (zh) * | 2012-11-21 | 2015-09-23 | 杜克大学 | 用于人肿瘤的溶瘤脊髓灰质炎病毒 |
| IL292510A (en) | 2013-11-05 | 2022-06-01 | Cognate Bioservices Inc | Combinations of checkpoint inhibitors and therapeutics to treat cancer |
| US10835595B2 (en) * | 2014-01-06 | 2020-11-17 | The Trustees Of The University Of Pennsylvania | PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy |
| EP3110443A4 (en) | 2014-02-27 | 2017-11-15 | Viralytics Limited | Combination method for treatment of cancer |
-
2016
- 2016-10-14 WO PCT/US2016/057023 patent/WO2017066557A1/en not_active Ceased
- 2016-10-14 US US15/768,147 patent/US10744170B2/en active Active
- 2016-10-14 JP JP2018519304A patent/JP6850290B2/ja active Active
- 2016-10-14 CN CN201680060434.8A patent/CN108697788A/zh active Pending
- 2016-10-14 EP EP16856268.4A patent/EP3362091A4/en active Pending
-
2020
- 2020-07-31 JP JP2020129898A patent/JP2020183447A/ja not_active Withdrawn
- 2020-08-11 US US16/990,036 patent/US20200368300A1/en not_active Abandoned
-
2022
- 2022-10-21 JP JP2022168742A patent/JP2022183342A/ja active Pending
-
2023
- 2023-12-19 US US18/545,176 patent/US20240415906A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022183342A5 (https=) | ||
| JP2020183447A5 (https=) | ||
| Ali et al. | Sleep, immunity and inflammation in gastrointestinal disorders | |
| EP4509527A3 (en) | Post-translationally modified fully human antibody therapeutic agents | |
| Natah et al. | Effects of acute hypoxia and hyperthermia on the permeability of the blood-brain barrier in adult rats | |
| Leslie et al. | Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis | |
| JP2017506662A5 (https=) | ||
| JP2016199571A (ja) | 組み合わせ医薬組成物並びに回転性めまい、動揺病及び自律神経血管ジストニアを治療する方法 | |
| JP2021520368A5 (https=) | ||
| Pellegrini et al. | Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats | |
| JP2012522788A5 (https=) | ||
| US8703124B2 (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system | |
| JP2018508208A5 (https=) | ||
| James et al. | How murine models of human disease and immunity are influenced by housing temperature and mild thermal stress | |
| Yuan et al. | Screening for protective antigens of Cyprinid herpesvirus 2 and construction of DNA vaccines | |
| JP5688699B2 (ja) | がん細胞を用いた免疫方法 | |
| Romero | Enteroviruses | |
| Zhao et al. | Protective immunity against infectious spleen and kidney necrosis virus induced by mannose modified subunit vaccine with carbon nanotubes in mandarin fish | |
| Jiang et al. | The phosphoinositide 3-kinase inhibitor ZSTK474 increases the susceptibility of osteosarcoma cells to oncolytic vesicular stomatitis virus VSVΔ51 via aggravating endoplasmic reticulum stress | |
| WO2024193321A1 (zh) | Glyt1抑制剂在治疗器官纤维化中的应用 | |
| EP1383872A2 (de) | Genmodifizierte yt zelllinie und ihre verwendung | |
| CN117264904A (zh) | 一种靶向HER2的γδT细胞及其制备方法与应用 | |
| CN115109161A (zh) | 含有间充质干细胞的减肥药物组合物 | |
| Kleinovink et al. | Combination of Photodynamic Therapy and Immune Checkpoint Blockade | |
| Soliman et al. | Development and production of Rabies virus-specific monoclonal antibodies and evaluation of their neutralizing and protective potentials |